IRIX Bull Call Spread Strategy
IRIX (IRIDEX Corporation), in the Healthcare sector, (Medical - Devices industry), listed on NASDAQ.
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally.
IRIX (IRIDEX Corporation) trades in the Healthcare sector, specifically Medical - Devices, with a market capitalization of approximately $17.9M, a beta of 0.65 versus the broader market, a 52-week range of 0.87-1.65, average daily share volume of 258K, a public-listing history dating back to 1996, approximately 93 full-time employees. These structural characteristics shape how IRIX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.65 indicates IRIX has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a bull call spread on IRIX?
A bull call spread buys an at-the-money call and sells an out-of-the-money call at a higher strike for defined risk and defined reward bounded by the strike width.
Current IRIX snapshot
As of May 15, 2026, spot at $1.03, ATM IV 22.70%, IV rank 1.34%, expected move 6.51%. The bull call spread on IRIX below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this bull call spread structure on IRIX specifically: IRIX IV at 22.70% is on the cheap side of its 1-year range, which favors premium-buying structures like a IRIX bull call spread, with a market-implied 1-standard-deviation move of approximately 6.51% (roughly $0.07 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated IRIX expiries trade a higher absolute premium for lower per-day decay. Position sizing on IRIX should anchor to the underlying notional of $1.03 per share and to the trader's directional view on IRIX stock.
IRIX bull call spread setup
The IRIX bull call spread below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With IRIX near $1.03, the first option leg uses a $1.03 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed IRIX chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 IRIX shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $1.03 | N/A |
| Sell 1 | Call | $1.08 | N/A |
IRIX bull call spread risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals strike width minus net debit times 100; max loss equals net debit times 100. Breakeven is long-call strike plus net debit.
IRIX bull call spread payoff curve
Modeled P&L at expiration across a range of underlying prices for the bull call spread on IRIX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use bull call spread on IRIX
Bull call spreads on IRIX reduce the cost of a bullish IRIX stock position by selling a higher-strike call; suited to moderate-move theses where price reaches but does not vastly exceed the short strike.
IRIX thesis for this bull call spread
The market-implied 1-standard-deviation range for IRIX extends from approximately $0.96 on the downside to $1.10 on the upside. A IRIX bull call spread caps both the risk and the reward of a bullish position; relative to an outright long call on IRIX, the spread reduces the cost basis but limits the maximum profit to the strike width minus net debit. Current IRIX IV rank near 1.34% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on IRIX at 22.70%. As a Healthcare name, IRIX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to IRIX-specific events.
IRIX bull call spread positions are structurally moderately bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. IRIX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move IRIX alongside the broader basket even when IRIX-specific fundamentals are unchanged. Long-premium structures like a bull call spread on IRIX are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current IRIX chain quotes before placing a trade.
Frequently asked questions
- What is a bull call spread on IRIX?
- A bull call spread on IRIX is the bull call spread strategy applied to IRIX (stock). The strategy is structurally moderately bullish: A bull call spread buys an at-the-money call and sells an out-of-the-money call at a higher strike for defined risk and defined reward bounded by the strike width. With IRIX stock trading near $1.03, the strikes shown on this page are snapped to the nearest listed IRIX chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are IRIX bull call spread max profit and max loss calculated?
- Max profit equals strike width minus net debit times 100; max loss equals net debit times 100. Breakeven is long-call strike plus net debit. For the IRIX bull call spread priced from the end-of-day chain at a 30-day expiry (ATM IV 22.70%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a IRIX bull call spread?
- The breakeven for the IRIX bull call spread priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current IRIX market-implied 1-standard-deviation expected move is approximately 6.51%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a bull call spread on IRIX?
- Bull call spreads on IRIX reduce the cost of a bullish IRIX stock position by selling a higher-strike call; suited to moderate-move theses where price reaches but does not vastly exceed the short strike.
- How does current IRIX implied volatility affect this bull call spread?
- IRIX ATM IV is at 22.70% with IV rank near 1.34%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.